Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.